Nouscom
PrivateLast Round
Series C
Mar 21, 2024
Total Funding Raised
$226.6M
Company Overview
Nouscom is a biotechnology company that develops engineered viral vector vaccines for cancer treatment.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nouscom Comparables
Compare Nouscom with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Transgene SA | 80% | |
| Gritstone bio | 78% | |
| Nykode Therapeutics | 78% | |
Nouscom Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Mar 21, 2024 | ||||
| Series C | Nov 14, 2023 | ||||
| Series B | Nov 6, 2017 | ||||
| Series A | May 17, 2016 |
Key People
Founding team and executive leadership
Nouscom Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| EQT Life Sciences | Series C, Series B, Series A |
| XGEN Venture | Series C |
| Andera Partners | Series C |
| M Ventures | Series C |
| Indaco Venture Partners SGR | Series C |
| 5AM Ventures | Series B, Series C |
| Versant Ventures | Series B, Series C, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 21, 2024
$82M round led by Andera Partners and M Ventures.
- Nov 14, 2023
$82M round raised
Nouscom Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nouscom's valuation, stock price, and market status.